| Status: Medicine does not meet criteria for AWMSG assessment | |
Excluded from appraisal by AWMSG as meets exclusion criteria 5. See AWMSG criteria for appraising a medicine (PDF, 430Kb) for information. |
|
Medicine details |
|
| Medicine name | clindamycin (as phosphate)/tretinoin (Treclin®) |
| Formulation | 10 mg (1%)/0.25 mg (0.025%) gel |
| Reference number | 2524 |
| Indication | Topical treatment of acne vulgaris when comedomes, papules and pustules are present in patients 12 years or older. Consideration should be given to official guidance on the appropriate use of antibacterial agents and acne treatment |
| Company | Meda Pharmaceuticals Ltd |
| BNF chapter | Skin |
| Submission type | N/A |
| Status | Medicine does not meet criteria for AWMSG assessment |
| Date of issue | 06/05/2014 |